Paloma Partners Management CO Amgen Inc Call Options Transaction History

Paloma Partners Management CO

$3.08 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $5.83 Million - $6.58 Million	22,800 New	22,800 $6.57 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $6.41 Million - $7.58 Million	29,900 New	29,900 $6.64 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $9.02 Million - $11.5 Million	39,400 New	39,400 $10.3 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $25.5 Million - $28.2 Million	-116,200 Reduced 88.23%	15,500 $3.75 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $26.2 Million - $30 Million	131,700 New	131,700 $29.6 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $350,370 - $388,710	-1,500 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $1.95 Million - $2.28 Million	-8,800 Reduced 85.44%	1,500 $373,000
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $2.23 Million - $2.65 Million	10,300 New	10,300 $2.37 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $211,185 - $234,855	-900 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $336,277 - $412,658	-1,700 Reduced 65.38%	900 $212,000
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $8.47 Million - $11.2 Million	-46,500 Reduced 94.7%	2,600 $527,000
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $7.53 Million - $9.68 Million	39,800 Added 427.96%	49,100 $11.8 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $2.14 Million - $2.57 Million	-12,300 Reduced 56.94%	9,300 $1.8 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $3.2 Million - $3.74 Million	-18,900 Reduced 46.67%	21,600 $3.68 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $827,071 - $924,091	-4,900 Reduced 10.79%	40,500 $7.04 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $7.59 Million - $8.67 Million	45,400	45,400 $8.47 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Account